Compare EZGO & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZGO | POM |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Other Specialty Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 38.8M |
| IPO Year | 2021 | 2025 |
| Metric | EZGO | POM |
|---|---|---|
| Price | $1.57 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 84.0K | ★ 486.1K |
| Earning Date | 07-01-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,486,067.00 | ★ $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.42 | 12.13 |
| 52 Week Low | $1.42 | $0.22 |
| 52 Week High | $17.24 | $6.43 |
| Indicator | EZGO | POM |
|---|---|---|
| Relative Strength Index (RSI) | 35.15 | 25.18 |
| Support Level | $1.70 | $0.22 |
| Resistance Level | $2.10 | $0.26 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 7.32 | 9.72 |
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.